Stock Events

Stock Events

Ritter Pharmaceuticals 

0
41
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18AugExpected
Q1 2024
Next
-23.94
-23.6
-23.27
-22.94
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-16.83MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7R9A.MU. It's not an investment recommendation.
Schwab US Dividend Equity
2
SCHD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is a biopharmaceutical company that competes in the development of therapeutics in areas similar to Qualigen, such as viral diseases, making it a direct competitor.
AMGEN
AMGN
Mkt Cap196.12B
Amgen is a biotech firm focusing on human therapeutics, including treatments for illnesses that Qualigen also targets, positioning it as a competitor.
Bristol-Myers Squibb
BMY
Mkt Cap117.58B
Bristol Myers Squibb operates in the biopharmaceutical field, developing prescription drugs that overlap with Qualigen's therapeutic areas.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a global pharmaceutical corporation with a broad product portfolio that includes treatments in areas competing with Qualigen's focus.
Merck
MRK
Mkt Cap305.12B
Merck & Co. is known for its innovative medicines and vaccines, some of which directly compete with Qualigen's product pipeline.
Abbvie
ABBV
Mkt Cap438.31B
AbbVie is a research-based biopharmaceutical company with a strong emphasis on developing innovative therapies, including those in competition with Qualigen.
Regeneron Pharmaceuticals
REGN
Mkt Cap69.67B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious conditions, competing with Qualigen's therapeutic areas.
Vertex Pharmaceuticals
VRTX
Mkt Cap123.19B
Vertex Pharmaceuticals is focused on creating new possibilities in medicine to cure diseases and improve people's lives, including areas where Qualigen operates.
Novartis
NVS
Mkt Cap293.94B
Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including in sectors where Qualigen is active.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of medical therapies that compete with Qualigen's developments.

About

Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Show more...
CEO
Mr. Michael S. Poirier
Employees
4
Country
United States
ISIN
US7678363075

Listings

MU
DE
7R9A.MU
STU
DE
7R90.STU
F
DE
7R90.F
MU
DE
7R90.MU

0 Comments

Share your thoughts

FAQ

What is Ritter Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Ritter Pharmaceuticals stocks are traded under the ticker 7R9A.MU.
When is the next Ritter Pharmaceuticals earnings date?▼
Ritter Pharmaceuticals is going to release the next earnings report on August 18, 2026.
What is Ritter Pharmaceuticals revenue for the last year?▼
Ritter Pharmaceuticals revenue for the last year amounts to 0 EUR.
What is Ritter Pharmaceuticals net income for the last year?▼
7R9A.MU net income for the last year is -16.83M EUR.
How many employees does Ritter Pharmaceuticals have?▼
As of July 15, 2026, the company has 4 employees.
In which sector is Ritter Pharmaceuticals located?▼
Ritter Pharmaceuticals operates in the Health & Wellness sector.
When did Ritter Pharmaceuticals complete a stock split?▼
Ritter Pharmaceuticals has not had any recent stock splits.
Where is Ritter Pharmaceuticals headquartered?▼
Ritter Pharmaceuticals is headquartered in Carlsbad, United States.